Extracted from this filing and checked against the source text.
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
INTENSITY THERAPEUTICS, INC.: Adopted amended and restated Bylaws effective upon closing of the Offering (effective 2023-07-05).
- Change
- bylaw amendment
- Effective
- 2023-07-05
Exact text from the filing
In connection with the closing of the Offering, effective as of July 5, 2023, the Company adopted amended and restated bylaws (the “ Amended and Restated Bylaws ”).
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
INTENSITY THERAPEUTICS, INC.: Filed Sixth Amended and Restated Certificate of Incorporation in connection with closing of the initial public offering (effective 2023-06-30).
- Change
- charter amendment
- Effective
- 2023-06-30
Exact text from the filing
In connection with the closing of the Offering, on June 30, 2023, the Company filed its Sixth Amended and Restated Certificate of Incorporation (the “ Sixth Amended and Restated Charter ”).
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.95
INTENSITY THERAPEUTICS, INC. entered into Underwriting Agreement with The Benchmark Company, LLC valued at Total gross proceeds of $19,500,000 from sale of 3,900,000 shares at $5.00 per share (effective 2023-06-29).
- Action
- entry
- Agreement
- underwriting
- Counterparty
- The Benchmark Company, LLC
- Value
- Total gross proceeds of $19,500,000 from sale of 3,900,000 shares at $5.00 per share
- Effective
- 2023-06-29
Exact text from the filing
On June 29, 2023, Intensity Therapeutics, Inc. (the “ Company ”) entered into an Underwriting Agreement (the “ Underwriting Agreement ”) with The Benchmark Company, LLC, as representative of the underwriters named on Schedule 1 thereto (the “Representative ”) relating to the Company’s firm commitment underwritten initial public offering (the “ Offering ”) of common stock, par value $0.0001 per share (the “ Common Stock ”), which was registered under the Securities Act of 1933, as amended (the “ Securities Act ”) by the Company’s registration statement on Form S-1, as amended (File No. 333-260565) (the “ Registration Statement ”).
View on SEC.gov